Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.12T | 2.10T | 2.18T | 2.18T | 1.90T | 1.48T | Gross Profit |
643.30B | 603.02B | 584.52B | 584.52B | 563.85B | 434.32B | EBIT |
199.59B | 172.89B | 168.83B | 168.83B | 166.78B | 111.53B | EBITDA |
387.79B | 355.47B | 364.01B | 337.67B | 273.10B | 222.85B | Net Income Common Stockholders |
169.59B | 124.69B | 114.19B | 131.30B | 131.30B | 79.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
324.54B | 650.00B | 558.33B | 558.33B | 506.28B | 446.33B | Total Assets |
2.02T | 3.42T | 3.15T | 3.15T | 3.04T | 2.40T | Total Debt |
532.07B | 685.74B | 752.16B | 752.16B | 679.81B | 521.61B | Net Debt |
238.56B | 35.74B | 245.97B | 245.97B | 240.47B | 141.23B | Total Liabilities |
1.15T | 1.70T | 1.68T | 1.68T | 1.74T | 1.40T | Stockholders Equity |
863.35B | 1.71T | 1.46T | 1.46T | 1.30T | 1.00T |
Cash Flow | Free Cash Flow | ||||
261.51B | 228.42B | -12.94B | -12.94B | -112.35B | 10.46B | Operating Cash Flow |
462.25B | 447.01B | 262.77B | 262.77B | 178.99B | 222.81B | Investing Cash Flow |
-222.83B | -216.59B | -234.40B | -234.40B | -281.55B | -231.49B | Financing Cash Flow |
-184.68B | -146.37B | 14.95B | 14.95B | 113.74B | 29.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $169.89B | 16.42 | 41.96% | 2.18% | 12.13% | 36.17% | |
75 Outperform | $787.25B | 80.76 | 14.85% | 1.30% | 40.30% | -22.79% | |
73 Outperform | $19.95B | 18.02 | 9.28% | 1.21% | -4.18% | 67.36% | |
71 Outperform | $100.02B | 64.31 | 4.43% | 1.82% | -19.28% | -44.00% | |
67 Neutral | $48.20B | 19.32 | 28.16% | 2.13% | -4.99% | -9.18% | |
65 Neutral | $163.51B | 34.58 | 28.25% | 2.96% | -10.72% | -26.60% | |
57 Neutral | $20.89B | 10.40 | -13.99% | 2.52% | 4.47% | -23.34% |